ES2173968T3 - Compuesto oxidente heterociclico de tres ciclos fusinados. - Google Patents

Compuesto oxidente heterociclico de tres ciclos fusinados.

Info

Publication number
ES2173968T3
ES2173968T3 ES95932928T ES95932928T ES2173968T3 ES 2173968 T3 ES2173968 T3 ES 2173968T3 ES 95932928 T ES95932928 T ES 95932928T ES 95932928 T ES95932928 T ES 95932928T ES 2173968 T3 ES2173968 T3 ES 2173968T3
Authority
ES
Spain
Prior art keywords
compound
group
sub
antioxidant
heterociclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95932928T
Other languages
English (en)
Inventor
Shuji Jinno
Yasuyo Kogure
Hiroyuki Onuki
Takaaki Okita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissui Corp
Original Assignee
Nippon Suisan Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Suisan Kaisha Ltd filed Critical Nippon Suisan Kaisha Ltd
Application granted granted Critical
Publication of ES2173968T3 publication Critical patent/ES2173968T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/14—[b,f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/14—[b,f]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

SE PRESENTA UN NUEVO COMPUESTO HETEROCICLICO CONDENSADO TRICICLICO QUE POSEE UNA ACCION ANTIOXIDANTE Y ES ADECUADO PARA SU USO EN AGENTES FARMACEUTICOS, COSMETICOS, PRODUCTOS QUIMICOS Y SIMILARES. MEDIANTE UNA SINTESIS QUIMICA SE OBTIENEN UN NUEVO COMPUESTO HETEROCICLICO CONDENSADO, TRICICLICO, ANTIOXIDANTE REPRESENTADO POR LA FORMULA SIGUIENTE: (EN LA QUE X E Y REPRESENTAN CH{SUB,2} ENTA O, S O S=O; DE R{SUB,1} A R{SUB,8} REPRESENTAN, INDEPENDIENTEMENTE, AQUELLOS SELECCIONADOS DEL GRUPO QUE CONSISTE EN UN ATOMO DE HIDROGENO, UN GRUPO HIDROXILO, UN GRUPO HALOGENO, UN GRUPO ALKILO INFERIOR, UN GRUPO ALCOXI INFERIOR, UN GRUPO ALKILCETONA INFERIOR Y CF{SUB,3}; AL MENOS DOS DE ENTRE R{SUB,1} A R{SUB,4} SON GRUPOS HIDROXILO); Y LAS SALES DEL MISMO. EL COMPUESTO TIENE UNA ACTIVIDAD ANTIOXIDANTE AL GRADO DE VENTA IGUAL O SUPERIOR QUE LA ACTIVIDAD DEL {AL} EL COMPUESTO ES UTIL COMO FARMACO TERAPEUTICO PARA UNA VARIEDAD DE ENFERMEDADES, TALES COMO EL CANCER, ARTERIOSCLEROSIS, O ENFERMEDADES HEPATICAS, EN LAS QUE SE CREE QUE PUEDEN INTERVENIR PEROXIDOS DE LIPIDOS BIOLOGICOS.
ES95932928T 1994-09-28 1995-09-28 Compuesto oxidente heterociclico de tres ciclos fusinados. Expired - Lifetime ES2173968T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25878194 1994-09-28
JP3317895 1995-01-30

Publications (1)

Publication Number Publication Date
ES2173968T3 true ES2173968T3 (es) 2002-11-01

Family

ID=26371823

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95932928T Expired - Lifetime ES2173968T3 (es) 1994-09-28 1995-09-28 Compuesto oxidente heterociclico de tres ciclos fusinados.

Country Status (10)

Country Link
US (1) US5734067A (es)
EP (1) EP0805155B1 (es)
JP (1) JP3328673B2 (es)
AT (1) ATE214386T1 (es)
CA (1) CA2200598C (es)
DE (1) DE69525859T2 (es)
DK (1) DK0805155T3 (es)
ES (1) ES2173968T3 (es)
PT (1) PT805155E (es)
WO (1) WO1996010021A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0885610A4 (en) * 1996-01-19 1999-04-21 Nippon Suisan Kaisha Ltd Tracheal smooth muscle relaxant
KR20020016812A (ko) 1999-06-03 2002-03-06 구니이 야스오 트리시클릭 융합 헤테로사이클 화합물, 상기물의 제조방법 및 그의 용도
EP1197211A4 (en) 1999-07-19 2004-09-01 Sankyo Co CANCER PREVENTION AND TREATMENT ACTIVE INGREDIENTS
JP2007230866A (ja) * 2004-02-20 2007-09-13 Nippon Suisan Kaisha Ltd 高尿酸血症治療剤
CN101626787A (zh) * 2007-01-19 2010-01-13 马林克罗特公司 诊断的和治疗的环氧合酶-2结合配体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3068250D1 (en) * 1979-11-27 1984-07-19 Merck Sharp & Dohme 3-hydroxymethyldibenzo(b,f)thiepins and dibenzo(b,f)thiepin-3-carboxaldehydes as prostaglandin antagonists, process for their preparation and pharmaceutical compositions
JPS56166180A (en) * 1980-05-28 1981-12-21 Chugai Pharmaceut Co Ltd Dibenzoxazepine derivative and its preparation
JPH05153990A (ja) * 1991-12-06 1993-06-22 Nippon Suisan Kaisha Ltd 新規ジベンゾオキセピン誘導体

Also Published As

Publication number Publication date
DE69525859T2 (de) 2002-10-24
PT805155E (pt) 2002-09-30
JP3328673B2 (ja) 2002-09-30
CA2200598A1 (en) 1996-04-04
CA2200598C (en) 1999-12-07
DE69525859D1 (de) 2002-04-18
WO1996010021A1 (en) 1996-04-04
EP0805155A4 (en) 1998-01-07
EP0805155A1 (en) 1997-11-05
ATE214386T1 (de) 2002-03-15
US5734067A (en) 1998-03-31
EP0805155B1 (en) 2002-03-13
DK0805155T3 (da) 2002-07-08

Similar Documents

Publication Publication Date Title
AR021844A1 (es) Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion
NO20000572L (no) Indolderivater som MCP-1 reseptor antagonister
ECSP034914A (es) "azaindoles"
ES2193142T3 (es) Uso de benzotiofenos para el tratamiento de hipercolesterolemia.
AR029383A1 (es) Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes
ES2138977T3 (es) Agonistas muscarinicos.
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
AR057873A2 (es) Compuestos derivados de piperizina utiles como antagonistas ccr5, composiciones farmaceuticas que los comprenden, y el uso de los mismos para la preparacion de medicamentos
ES2147759T3 (es) Heterociclos no aromaticos sustituidos con aminometileno y uso como antagonistas de la sustancia p.
BRPI0111639B8 (pt) uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica.
AR006119A1 (es) Compuestos de quinoxalinadionas uso de los mismos para la fabricacion de un medicamento, compuestos de quinoxalinas para producirlos y procedimiento parala preparacion de los mismos
AR032607A1 (es) Composiciones farmaceuticas que contienen sales de hidroxieicosatetraenoato, y el uso de las mismas para la manufactura de un medicamento para el tratamiento de desordenes del ojo seco
ES2051479T3 (es) Uso de imidazoles substituidos en 4 para disminuir la presion intraocular.
MX9306311A (es) Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
UY26920A1 (es) 7 - oxo piridopirimidinas
ES452200A1 (es) Un procedimiento para la preparacion de nuevos derivados de pipendina.
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
ES2151168T3 (es) N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
NO20014240D0 (no) C16-umettede FP-selektive prostaglandinanaloger
AR030788A1 (es) Antagonistas de receptores de taquiquinina zwitterionica
AR004215A1 (es) Compuestos sulfonamidas, un procedimiento para su preparación, composición farmacéutica que los contiene, compuestos intermediarios, empleo de los compuestos sulfonamidas para la preparacion de un medicamento útil en trastornos asociados con la actividad de la endotelina.
ES2059130T3 (es) Composiciones farmaceuticas que contienen ipriflavona, procedimiento para su preparacion y uso terapeutico relacionado.
ES2193248T3 (es) Antraquinonas mono- y disulfosustituidas y su uso para el tratamiento de desordenes de la matriz osea.
YU37597A (en) New pyranosid derivatives
UY27324A1 (es) Nuevas sales de napsilato i

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 805155

Country of ref document: ES